BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Szlendak U, Bykowska K, Lipniacka A. Clinical, Biochemical and Molecular Characteristics of the Main Types of Porphyria. Adv Clin Exp Med 2016;25:361-8. [PMID: 27627571 DOI: 10.17219/acem/58955] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Savino M, Guida CC, Nardella M, Murgo E, Augello B, Merla G, De Cosmo S, Savino AF, Tarquini R, Cei F, Aucella F, Mazzoccoli G. Circadian Genes Expression Patterns in Disorders Due to Enzyme Deficiencies in the Heme Biosynthetic Pathway. Biomedicines 2022;10. [PMID: 36551954 DOI: 10.3390/biomedicines10123198] [Reference Citation Analysis]
2 Fabian E, Reisinger A, Ribitsch W, Stadlbauer V, Eherer AJ, Roller-wirnsberger R, Toplak H, Fickert P, Krejs GJ. Clinical-Pathological Conference Series from the Medical University of Graz. Wien Klin Wochenschr 2022. [DOI: 10.1007/s00508-022-02097-w] [Reference Citation Analysis]
3 Moshayedi A, Mochel MC, Brooks AN, Laver J, Salkey KS. A 9-year-old girl with blisters on the hands and face: An early presentation of variegate porphyria. Pediatr Dermatol 2022. [PMID: 36178265 DOI: 10.1111/pde.15150] [Reference Citation Analysis]
4 Ricci A, Di Betto G, Bergamini E, Buzzetti E, Corradini E, Ventura P. Iron Metabolism in the Disorders of Heme Biosynthesis. Metabolites 2022;12:819. [DOI: 10.3390/metabo12090819] [Reference Citation Analysis]
5 Wylie K, Testai FD. Neurological Manifestations of Acute Porphyrias. Curr Neurol Neurosci Rep 2022. [PMID: 35665475 DOI: 10.1007/s11910-022-01205-7] [Reference Citation Analysis]
6 Longo M, Paolini E, Meroni M, Dongiovanni P. Cutting-Edge Therapies and Novel Strategies for Acute Intermittent Porphyria: Step-by-Step towards the Solution. Biomedicines 2022;10:648. [DOI: 10.3390/biomedicines10030648] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Sardh E, Harper P. RNAi therapy with givosiran significantly reduces attack rates in acute intermittent porphyria. J Intern Med. [DOI: 10.1111/joim.13443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Sirch C, Khanna N, Frassetto L, Bianco F, Artero ML. Diagnosis of acute intermittent porphyria in a renal transplant patient: A case report. World J Transplant 2022; 12(1): 8-14 [DOI: 10.5500/wjt.v12.i1.8] [Reference Citation Analysis]
9 Ricci A, Guida CC, Manzini P, Cuoghi C, Ventura P. Kidney Involvement in Acute Hepatic Porphyrias: Pathophysiology and Diagnostic Implications. Diagnostics (Basel) 2021;11:2324. [PMID: 34943561 DOI: 10.3390/diagnostics11122324] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Sarró-Fuente C, Martín-Alcalde J, Pampín-Franco A, Palencia-Pérez SI, López-Estebaranz JL. Hypertrichosis and blisters in an infant. Pediatr Dermatol 2021;38:688-90. [PMID: 34224613 DOI: 10.1111/pde.14574] [Reference Citation Analysis]
11 Micaglio E, Locati ET, Monasky MM, Romani F, Heilbron F, Pappone C. Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine. Front Pharmacol 2021;12:651720. [PMID: 33995067 DOI: 10.3389/fphar.2021.651720] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
12 Gill L, Burrell S, Chamberlayne J, Lombardelli S, Mora J, Mason N, Schurer M, Merkel M, Meninger S, Ko JJ. Patient and caregiver experiences of living with acute hepatic porphyria in the UK: a mixed-methods study. Orphanet J Rare Dis 2021;16:187. [PMID: 33902669 DOI: 10.1186/s13023-021-01816-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Nunnemann S, Uibel C, Budig P, Mäurer M. Acute intermittent porphyria (AIP) in a patient with celiac disease. Neurol Res Pract 2020;2:2. [PMID: 33324908 DOI: 10.1186/s42466-020-0049-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Ma Y, Teng Q, Zhang Y, Zhang S. Acute intermittent porphyria: focus on possible mechanisms of acute and chronic manifestations. Intractable Rare Dis Res 2020;9:187-95. [PMID: 33139977 DOI: 10.5582/irdr.2020.03054] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ma L, Tian Y, Peng C, Zhang Y, Zhang S. Recent advances in the epidemiology and genetics of acute intermittent porphyria. Intractable Rare Dis Res 2020;9:196-204. [PMID: 33139978 DOI: 10.5582/irdr.2020.03082] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
16 Cohen AM, Chamberlin S, Deloughery T, Nguyen M, Bedrick S, Meninger S, Ko JJ, Amin JJ, Wei AJ, Hersh W. Detecting rare diseases in electronic health records using machine learning and knowledge engineering: Case study of acute hepatic porphyria. PLoS One 2020;15:e0235574. [PMID: 32614911 DOI: 10.1371/journal.pone.0235574] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
17 Cohen A, Chamberlin S, Deloughery T, Nguyen M, Bedrick S, Meninger S, Ko JJ, Amin J, Wei A, Hersh W. Detecting Rare Diseases in Electronic Health Records Using Machine Learning and Knowledge Engineering: Case Study of Acute Hepatic Porphyria.. [DOI: 10.1101/2020.04.09.20052449] [Reference Citation Analysis]
18 Al‐hage J, Nemer G, Kassabian P, Kurban M. Unusual presentation of severe photosensitivity and neurodevelopmental delay in a consanguineous family. Clin Exp Dermatol 2020;45:117-119. [DOI: 10.1111/ced.13948] [Reference Citation Analysis]
19 Spiritos Z, Salvador S, Mosquera D, Wilder J. Acute Intermittent Porphyria: Current Perspectives And Case Presentation. Ther Clin Risk Manag 2019;15:1443-51. [PMID: 31908464 DOI: 10.2147/TCRM.S180161] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
20 Varjú C, Kumánovics G, Czirják L, Matucci-Cerinic M, Minier T. Sclerodermalike syndromes: Great imitators. Clin Dermatol 2020;38:235-49. [PMID: 32513403 DOI: 10.1016/j.clindermatol.2019.10.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
21 Karaca Ç. Extrahepatic Manifestations of Hepatitis C Virus Infection. Viral Hepatitis: Chronic Hepatitis C 2019. [DOI: 10.1007/978-3-030-03757-4_10] [Reference Citation Analysis]
22 Müller F, Sharma A, König J, Fromm MF. Biomarkers for In Vivo Assessment of Transporter Function. Pharmacol Rev 2018;70:246-77. [PMID: 29487084 DOI: 10.1124/pr.116.013326] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 8.2] [Reference Citation Analysis]
23 Nunnemann S. Enzymdefekt mit schweren Folgen. DNP 2018;19:26-30. [DOI: 10.1007/s15202-018-1986-6] [Reference Citation Analysis]
24 Duque-serrano L, Patarroyo-rodriguez L, Gotlib D, Molano-eslava JC. Psychiatric Aspects of Acute Porphyria: a Comprehensive Review. Curr Psychiatry Rep 2018;20. [DOI: 10.1007/s11920-018-0867-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
25 Pallet N, Karras A, Thervet E, Gouya L, Karim Z, Puy H. Porphyria and kidney diseases. Clin Kidney J 2018;11:191-7. [PMID: 29644058 DOI: 10.1093/ckj/sfx146] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
26 Potekaev NN, Karpov LL, Dolya OV, Markova MN. Late skin porphyria as a rare case of extrahepatic manifestations of chronic hepatitis C in a patient with a history of syphilis. Klin dermatol venerol 2018;17:119. [DOI: 10.17116/klinderma201817051119] [Reference Citation Analysis]
27 Komac A, Gram E, Gulec F, Akar H. Secret Underlying Unexplained Abdominal Pain, Neurological Symptoms and Intermittent Hypertension: Acute Intermittent Porphyria. BANTAO Journal 2017;15:35-8. [DOI: 10.1515/bj-2017-0009] [Reference Citation Analysis]
28 Gordon SC, Gonzalez HC. Hepatic Manifestations of Systemic Disorders. Schiff's Diseases of the Liver 2017. [DOI: 10.1002/9781119251316.ch8] [Reference Citation Analysis]
29 Sayiner M, Golabi P, Farhat F, Younossi ZM. Dermatologic Manifestations of Chronic Hepatitis C Infection. Clin Liver Dis 2017;21:555-64. [PMID: 28689593 DOI: 10.1016/j.cld.2017.03.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
30 Ajayi T, Ward R, Summers B, Byrns J, Kappus M, Choi S, Wilder J. Pathophysiology, Pharmacology and Treatment of Acute Intermittent Porphyria: A Patient Case Description and Recommendations from the Current Literature. Journal of Exploratory Research in Pharmacology 2017;2:49-53. [DOI: 10.14218/jerp.2016.00022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
31 Osternack BR. Porphyria: Analysis of Register from Brazilian Association of Porphyria (ABRAPO). HTIJ 2016;2. [DOI: 10.15406/htij.2016.02.00052] [Reference Citation Analysis]